Prospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Surg. Mar 27, 2019; 11(3): 169-178
Published online Mar 27, 2019. doi: 10.4240/wjgs.v11.i3.169
Table 3 Surgical outcomes
Overall1st quintile2nd quintile3rd quintile4th quintile5th quintileP value
(n = 380)(n = 76)(n = 76)(n = 76)(n = 76)(n = 76)
Time to resume normal diet (d)2 (1-3)2 (1-3)1 (0-2)a2 (0-2.8)2 (1-3)2 (1-2)< 0.001a
Time to first bowel movement (d)3 (2-3)3 (2-3)3 (2-3)3 (2-3)2 (2-4)3 (2-3)0.848
Overall complication83 (21.8)18 (23.7)20 (26.3)16 (21.1)18 (23.7)11 (14.5)0.457
Major complication111 (2.9)1 (1.3)3 (3.9)2 (2.6)3 (3.9)2 (2.6)0.860
Hospital stay (d)4 (4-5)5 (4-7)b4 (4-5)4 (4-5)5 (4-5.8)4 (3-5)0.015a
Hospital stay >5 d86 (22.6)31 (40.8)c12 (15.8)15 (18.4)19 (25.0)10 (13.2)< 0.001a
30-d readmission9 (2.4)1 (1.3)05 (6.6)2 (2.6)1 (1.3)0.077
30-d mortality1 (0.3)01 (1.3)0000.405
ERAS compliance %73.5 ± 11.868.6 ± 16d75.4 ± 11.173.7 ± 9.974.3 ± 10.275.5 ± 9.5< 0.001 a
Optimal recovery2288 (75.0)44 (57.9)e64 (84.2)57 (75.0)55 (72.4)65 (85.5)< 0.001 a